Skip to main content
MPLT
NASDAQ Life Sciences

MapLight's ML-004 Phase 2 IRIS Trial Misses Primary Endpoint, Shows Strong Irritability Signal in Adolescents

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$25.92
Mkt Cap
$1.228B
52W Low
$12.24
52W High
$33.28
52W Position info
112% above low
Off High info
22% below high
Rel. Volume info
4.6× avg
Market data snapshot near publication time

MPLT has more than doubled off its 52-week low of $12.24 on elevated volume (4.6× avg).

Summary

MapLight's ML-004 Phase 2 IRIS trial missed its primary endpoint for social communication deficits in autism spectrum disorder. However, the drug demonstrated a statistically significant and clinically meaningful improvement in irritability within a prespecified adolescent subgroup, and was well-tolerated. This news follows an 8-K filed earlier today that briefly disclosed the trial results. While the primary endpoint miss is a setback, the positive irritability signal offers a potential new development path for ML-004. The company plans to engage the FDA in an End-of-Phase 2 meeting to determine next steps for development in irritability associated with ASD.

At the time of this announcement, MPLT was trading at $25.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $12.24 to $33.28. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

MPLT - Latest Insights

MPLT
Nov 16, 2026, 7:30 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.37
Real-time Price: $7.03 info
Change: -$0.340 (-5%) info
Market Cap: $383.472M info
MPLT
Nov 16, 2026, 7:20 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.37
Real-time Price: $7.03 info
Change: -$0.340 (-5%) info
Market Cap: $383.472M info
MPLT
Nov 16, 2026, 7:15 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $7.25
Real-time Price: $7.03 info
Change: -$0.220 (-3%) info
Market Cap: $383.472M info
MPLT
Aug 18, 2026, 6:55 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $11.59
Real-time Price: $7.03 info
Change: -$4.56 (-39%) info
Market Cap: $383.472M info
MPLT
Aug 18, 2026, 6:51 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $11.59
Real-time Price: $7.03 info
Change: -$4.56 (-39%) info
Market Cap: $383.472M info